BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2021
View Archived Issues
Surface Ophthalmics initiates phase II study of SURF-100 for chronic dry eye disease
Read More
Gray matter damage in MS starts at synapses
Read More
Few-shot learning enhances biomarker identification
Read More
CARB-X funding supports Lumen's development of immunotherapy to prevent diarrheal diseases
Read More
Contradictory results for FCGR2C gene allele regarding HIV-1 infection risk
Read More
PHA-121 demonstrates promising safety and PK profile in phase I study
Read More
Final analysis data presented from BLAZE-1 phase II/III study in mild-to-moderate COVID-19
Read More
BREEZE study of Tyvaso DPI dry powder formulation meets primary endpoint
Read More
PRV-3279 prevents immunogenicity in a preclinical model of gene therapy for Pompe disease
Read More
Tempol decreases cytokines from stimulated cells from patients with COVID-19
Read More
Sunshine Lake Pharma patents SGLT-1 inhibitors
Read More
EyePoint initiates phase I study of EYP-1901 for the treatment of wet AMD
Read More
ChemoCentryx synthesizes new PD-1/PD-L1 interaction inhibitors
Read More
Positive GLP toxicology study results presented for CBX-12
Read More
APX-005M regimen is active and tolerable in metastatic pancreatic adenocarcinoma trial
Read More
Idorsia Pharmaceuticals presents IDO1 and TDO inhibitors
Read More
FDA clears IND application for PBFT-02 gene therapy candidate
Read More
Sapience Therapeutics divulges BCL9 mimetic peptides for cancer
Read More
FDA approves IND application for Zofin in COPD
Read More
Progen patents new fusion proteins for allergic diseases
Read More
PF-06826647 is safe and significantly improves disease activity in subjects with plaque psoriasis
Read More
Novavax reports phase III data from U.K. trial of COVID-19 vaccine NVX-CoV2373
Read More
FDA lifts clinical hold on phase I/II trial of BPX-601
Read More
Kintor cleared to begin Brazilian trial of proxalutamide for hospitalized COVID-19 patients
Read More
Reduced TBX15 expression is a prognostic marker in patients with HCC
Read More
Macrophages key to liver cells relaxin'
Read More